ArticleDiabetes, obesity & metabolism2026
Highly Uncontrolled Cardiovascular Risk in Emerging Adults With Paediatric-Onset Type 1 Diabetes-A Cross-Sectional Analysis From the Diabetes Prospective Follow-Up Registry DPV.
Article in Diabetes, obesity & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
aimsCardiovascular disease (CVD) is a major contributor to premature morbidity and mortality in individuals with type 1 diabetes (T1DM). Glycaemic control often deteriorates during the transition from paediatric to adult care, and thus we assessed the prevalence and pharmacological management of overt and actionable modifiable cardiovascular risk factors in adolescents and young adults with paediatric-onset T1DM. We examined factors associated with risk burden and early microvascular complications.
methodsWe analysed data from 7298 individuals aged 17-26 years with paediatric-onset T1DM and ≥ 2 years diabetes duration in the DPV registry between 2020 and 2023. Five predefined CVD risk factors were assessed (HbA1c > 9%, obesity, elevated blood pressure, LDL > 130 mg/dL, smoking), using median values over a 3-year observation period. Factors associated with cumulative risk burden and associations with retinopathy and microalbuminuria were evaluated using multivariable linear and logistic regression models.
resultsAt least one CVD risk factor was present in 49.2% of individuals; 19.1% had ≥ 2 and 5.2% ≥ 3 risk factors. Poor glycaemic control, defined as HbA1c > 9% (21.8%) and elevated blood pressure (17.6%) was most frequent. CVD risk factor burden was associated with diabetes duration > 10 years and migration background. The likelihood of microalbuminuria increased progressively with the number of CVD risk factors, with an odds ratio of 2.68 (95% CI: 1.34-5.36) among individuals with four risk factors. Within this high-risk cohort, significant indication-treatment gaps remained: only 9.9% with overtly elevated LDL cholesterol > 130 mg/dL and 19.8% with hypertension > 140/90 mmHg received medication.
conclusionsYoung adults with paediatric-onset T1DM show a high burden of modifiable CVD risk factors with substantial treatment gaps, and clustering is associated with microvascular complications. Early identification and targeted intervention are critical to mitigating long-term vascular damage.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.